Header image

Session 8: Hemophilia

Tracks
Plenary Hall
Saturday, October 17, 2026
12:55 PM - 2:00 PM

Speaker

Agenda Item Image
Dr. Gerry Dolan
Consultant Haematologist and Hemophilia Centre Director
St Thomas’ Comprehensive Care Centre

Non-factor Replacement (Emicizumab/Fitusiran and other options)

1:15 PM - 1:35 PM

Biography

Dr. Gerry Dolan is a consultant hematologist and hemophilia centre director at St Thomas’ Comprehensive Care Centre, London, UK, and former centre director at Nottingham University Hospitals, Nottingham, UK. He is former chairman of the UK Hemophilia Centre Directors and president of the British Society for Haemostasias & Thrombosis. He has been an active participant in collaborative European initiatives in hemophilia and has chaired initiatives such as the ADVANCE group and the European Hemophilia Therapy Standardization Board. His interests include novel agents in the treatment of hemophilia, gene therapy and clinical outcomes.

Session Chair

Agenda Item Image
Shehab Fareed
Consultant Hematology
Hamad Medical Corporation - HMC

Agenda Item Image
Ahmad Tarawah
President, Madinah Hereditary Blood Disorders Society
President, Middle East and North Africa Hematology League





loading